UBS AM’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-1,829
| Closed | -$941K | – | 2730 |
|
|
2015
Q1 | $941K | Sell |
1,829
-2,229
| -55% | -$1.15M | ﹤0.01% | 1661 |
|
|
2014
Q4 | $2.17M | Buy |
4,058
+1,429
| +54% | +$765K | ﹤0.01% | 1289 |
|
|
2014
Q3 | $3.94M | Sell |
2,629
-1,681
| -39% | -$2.52M | ﹤0.01% | 1084 |
|
|
2014
Q2 | $5.9M | Buy |
4,310
+519
| +14% | +$711K | 0.01% | 994 |
|
|
2014
Q1 | $5.26M | Buy |
3,791
+913
| +32% | +$1.27M | 0.01% | 1028 |
|
|
2013
Q4 | $2.86M | Hold |
2,878
| – | – | ﹤0.01% | 1145 |
|
|
2013
Q3 | $3M | Hold |
2,878
| – | – | ﹤0.01% | 1105 |
|
|
2013
Q2 | $3.15M | Buy |
+2,878
| New | +$3.15M | ﹤0.01% | 1073 |
|